Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model

SHIMON BENITA*, AMNON HOFFMAN, MAX DONBROW

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Methacrylate copolymers were used for microencapsulation of paracetamol by phase separation from chloroform with polyisobutylene 6% in cyclohexane. With polyisobutylene as an anti‐aggregating agent, high quality microcapsules were obtained. Drug release appeared to fit both first order and Higuchi matrix model kinetics. However, on application of the differential rate treatment, the evidence supported the first order description, which was further supported by computed simulations of the models. Variation of production conditions showed that increasing the proportion of core material raised the microcapsule drug content and the release rate. Reduction of core particle size correlated with reduced coating thickness and faster release rate. The rate constants correlated with the estimated surface areas and wall thicknesses of the various batches. The data were used to estimate an apparent permeability constant for paracetamol in Eudragit RS microcapsules, which was constant and comparable with values found single core, non‐aggregated microcapsules containing other similar drugs and different wall materials. 1985 Royal Pharmaceutical Society of Great Britain

Original languageAmerican English
Pages (from-to)391-395
Number of pages5
JournalJournal of Pharmacy and Pharmacology
Volume37
Issue number6
DOIs
StatePublished - Jun 1985

Fingerprint

Dive into the research topics of 'Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model'. Together they form a unique fingerprint.

Cite this